Capture the IgAN Patient Experience Data Others Can't Reach

High-frequency, longitudinal Home Reported Outcomes (HROs) that connect patient quality of life with treatments and symptoms delivering the real-world evidence your strategy needs.

IgAN patients and providers have more treatment options than ever, but many trials still rely on the same endpoints. Folia provides contextualized patient data that shows what happens between clinic visits, including how patients feel, what they take, and the symptoms they experience in real time.

Capture benefits you’ve only ever heard anecdotally in a structured, patient-specific way, and let your product differentiation shine through our real-world evidence platform.

start learning

Fit-for-Purpose Evidence in IgAN Research

Our work in IgAN has been peer-reviewed, presented, and validated through partnerships with leading pharmaceutical innovators.

Folia Health’s IgAN abstract submissions have a 100% acceptance rate at major conferences.

See a sample of our recent work below:

  • NKF Folia Poster

    NKF 2025: Design of a Disease-Management App to Measure HROs in Pts With IgAN and C3G

    View Poster
  • ASN Folia IgAN poster

    ASN 2025: Baseline Characteristics and Treatment Satisfaction of Pts Enrolled in IgAN Bridge: Interim Results From a HROs Study

    View Poster

  • NORD 2025: Stratifying HomeReported Outcomes by Time Since Diagnosis in IgAN: Methodology and Early Findings

    view poster
  • NORD - IgAN HRO Outcomes Inventory

    NORD 2025: Assessing Alignment Between Standardized PROs and HROs in IgAN: Demonstrating the Value of HROs in Capturing the Full Patient Experience

    view abstract

  • March, 2025: Novartis Pharmaceuticals and Folia Health Partner on Innovative App-Based Study to Assess Real-World Experience of IgA Nephropathy

    Read Press Release

See How Folia Health Transforms IgAN Research

Folia Health collaborates with leading pharmaceutical companies to generate real-world evidence that supports drug development, regulatory submissions, market access strategies, and more.

Schedule a Consultation for:

  • Real IgAN data examples - See how we contextualize patient QoL, treatment patterns, and symptom experiences

  • Concurrent Phase 3 design - Learn how to deploy Folia alongside your clinical program

  • Patient engagement metrics - Understand our recruitment strategy and retention rates in IgAN populations

  • HEOR applications - Explore how our data strengthens value dossiers and payer discussions

  • Implementation timeline - Discuss fit with your development and commercialization plans